# Halma strengthens its Healthcare sector with acquisition of the TeDan group of companies

- Link: https://www.directorstalkinterviews.com/halma-strengthens-its-healthcare-sector-with-acquisition-of-the-tedan-group-of-companies/4121133350
- Published: 2023-11-20T07:17:19+00:00
- Author: Amilia Stone

**[Halma plc](https://www.directorstalkinterviews.com/ftse-company/halma-plc/hlma.l)**(
LON:HLMA), the global group of life-saving technology companies, has announced that
it has acquired the TeDan group of companies (TeDan), comprising the separate companies
of TeDan Surgical Innovations, Inc., West Coast Surgical, LLC, Axcess Surgical Innovations,
LLC and TeDan Surgical Innovations GmbH.

Headquartered in Houston, Texas and Half Moon Bay, California, USA, TeDan is a global
leader in innovative surgical access systems, which it develops, manufactures and
supplies to surgeons for use in a range of acute therapeutic procedures. Its primary
market is access systems for spinal surgery, and the USA accounts for the majority
of its sales. Further information on TeDan is given in the notes at the end of this
announcement.

The initial cash consideration for TeDan is US$89.1m (approximately £72m), on a 
cash- and debt-free basis, which will be funded from Halma’s existing facilities.
When adjusted for tax benefits with a net present value of approximately US$9.8 
million (approximately £8 million), the net initial consideration is approximately
US$79.3 million (approximately £64 million). An additional earn-out consideration
of up to US$10.9m (approximately £9m) is payable in cash, based on TeDan’s performance
in the period to June 2024.

TeDan’s consolidated unaudited revenue for the 12 months to 31 March 2023 was US
$29.2m (approximately £24m), and TeDan has a Return on Sales above the upper end
of Halma’s target range of 18-22%. TeDan will be a standalone company in Halma’s
Healthcare sector, led by its current management team.

> **Danny Fishman, Chief Executive Officer of TeDan, commented**: “World spending
> on healthcare is increasing as demand continues to grow, especially as the number
> of people over 60 has reached more than one billion. For over ten years, TeDan
> has been at the forefront of surgical access innovation, creating an improved 
> experience for surgeons in the operating room and better outcomes for patients.
> Joining Halma will help us to grow and invest in the U.S. and internationally.
> Together, we share a common purpose of ensuring a healthier future for everyone,
> every day.”

> **Marc Ronchetti, Group Chief Executive of Halma, commented**: “TeDan further 
> extends the technologies and capabilities of our Healthcare sector in the treatment
> of patients in acute therapeutic settings. TeDan’s growth is supported by the 
> growing need for surgical treatment as populations age and as lifestyles evolve
> and by the development of innovative new surgical procedures which improve efficiency
> and standards of care. We are delighted to welcome the TeDan team to Halma and
> look forward to working with them to expand their global impact.”

**Further information on TeDan**

The TeDan group of companies today comprises four distinct companies: 

·      TeDan Surgical Innovations, which develops and supplies surgical access systems;

·      West Coast Surgical, which manufactures these systems, offering complete 
design, manufacturing, and production assembly of surgical devices and instrumentation;

·      Axcess Surgical Innovations, which manufactures flexible and rigid arms and
retractor systems for surgical applications; and

·      TeDan Surgical Innovations GmbH, a new company, recently formed in response
to growing demand and business expansion in Europe.

TeDan has a portfolio of over 35 surgical access, exposure, holding and instrumentation
devices, which are sold both to leading medical device manufacturers, and under 
their own brand. Each of these devices is designed for a specific medical implant
or surgical procedure, in close partnership with their medical device manufacturing
customers.

TeDan’s devices are used primarily in spinal procedures, where TeDan’s products 
have a leading market position, as well as in neurological, cardiac and orthopaedic
surgeries.

TeDan has 16 active patents and 3 pending patents relating to its products.

Share on: